Kyle Diamantas’ temporary leadership will extend beyond 2 months

Diamantas, a Trump ally with regulatory and legal experience, was installed as interim leader amid pressure to stabilize the FDA. Given the Senate’s confirmation gridlock and internal agency vacancies, his tenure is expected to last longer than initially anticipated.

Implied probability (Yes)

60%